Il Yang licensing out Ilaprazole to Tap Co.

Published: 2005-09-13 07:00:00

Updated: 2005-09-13 07:00:00

Il yang announced on Sept. 7 that a technical transfer of Ilaprazole, an anti-peptic ulcer drug, was agreed with Tap Pharmaceutical Products Inc. in the United States (a joint venture company between Abbott of the United States ann Takeda of Japan) for its world distribution and marketing rights ...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK